Vicor Work in process increased by 29.6% to $19.38M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.7%, from $15.30M to $19.38M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 15.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.10M | $11.21M | $12.51M | $12.00M | $12.74M | $11.97M | $10.46M | $12.10M | $11.26M | $9.34M | $10.53M | $15.11M | $16.05M | $17.91M | $16.39M | $15.30M | $14.08M | $13.86M | $14.95M | $19.38M |
| QoQ Change | — | +10.9% | +11.7% | -4.1% | +6.1% | -6.0% | -12.6% | +15.7% | -7.0% | -17.1% | +12.7% | +43.6% | +6.2% | +11.6% | -8.5% | -6.7% | -8.0% | -1.6% | +7.9% | +29.6% |
| YoY Change | — | — | — | — | +26.1% | +6.8% | -16.4% | +0.9% | -11.6% | -22.0% | +0.7% | +24.9% | +42.6% | +91.8% | +55.7% | +1.2% | -12.3% | -22.6% | -8.8% | +26.7% |
| % of Inventories | 17.7% | 17.7% | 18.6% | 16.2% | 15.3% | 12.7% | 10.3% | 11.3% | 10.6% | 8.9% | 9.9% | 13.5% | 14.7% | 16.9% | 15.5% | 15.5% | 14.7% | 15.0% | 16.4% | 20.4% |
| Share Change | — | -0.0pp | +0.9pp | -2.3pp | -0.9pp | -2.6pp | -2.4pp | +1.0pp | -0.7pp | -1.6pp | +0.9pp | +3.6pp | +1.3pp | +2.2pp | -1.5pp | +0.1pp | -0.8pp | +0.3pp | +1.4pp | +4.1pp |